28 results
8-K
EX-99.1
BTTX
Better Therapeutics Inc
4 Mar 24
Regulation FD Disclosure
8:51am
, as a society, we’ve spent billions of dollars on developing drugs that lower blood sugar, lower blood pressure, cholesterol, and so on. But we spend very
424B3
BTTX
Better Therapeutics Inc
28 Dec 23
Prospectus supplement
9:23pm
in the Journal of the Endocrine Society. In our single-arm pilot study, the addition of the BT-001 treatment regimen to subjects who were, on average, already … research has been highlighted at several conferences including the American College of Lifestyle Medicine, IPSOR 2019, Endocrine 2020, the Society
8-K
EX-99.1
r66u33jy0k9bg79
12 Jul 23
Better Therapeutics Receives FDA Authorization for AspyreRxTM to Treat Adults with Type 2 Diabetes
12:00am
8-K
EX-99.1
v9ktma1nzuj3x26y6 44
14 Nov 22
Better Therapeutics Reports Third Quarter 2022 Financial Results and Provides
4:10pm
424B3
kgb sa24h3
7 Apr 22
Prospectus supplement
4:08pm
POS AM
d3w2f
1 Apr 22
Prospectus update (post-effective amendment)
4:25pm
424B3
wxvzscp
10 Dec 21
Prospectus supplement
6:06am
8-K
EX-99.1
dsk4gyiamrkwjrj54
18 Nov 21
Primary endpoint data expected in Q1 2022
8:31am
425
6688dm
20 Oct 21
Business combination disclosure
12:00am
424B3
1fg0s6
12 Oct 21
Prospectus supplement
5:13pm